Join

Compare · TMDX vs VRAY

TMDX vs VRAY

Side-by-side comparison of TransMedics Group Inc. (TMDX) and ViewRay Inc. (VRAY): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both TMDX and VRAY operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • TMDX is the larger of the two at $2.40B, about 3.3x VRAY ($726.7M).
  • TMDX has hit the wire 12 times in the past 4 weeks while VRAY has been quiet.
  • TMDX has more recent analyst coverage (18 ratings vs 9 for VRAY).
MetricTMDXVRAY
Company
TransMedics Group Inc.
ViewRay Inc.
Price
$71.52+3.10%
$0.03-39.95%
Market cap
$2.40B
$726.7M
1M return
-1.80%
-
1Y return
-48.72%
-
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
2019
News (4w)
12
0
Recent ratings
18
9
TMDX

TransMedics Group Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.

VRAY

ViewRay Inc.

ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Latest TMDX

Latest VRAY